Answer
Treatment should normally be postponed until after childbirth because pregnancy safety data are limited. Exceptional use needs specialist assessment.
Sources for this answer
- Fibrovein 3%, 1%, 0.5%, 0.2%emc · SmPC Current selected SmPC · Version 3
- NHSNHS · NHS medicine guidance